Claim · 1920 · Spectro-Chrome
The Spectro-Chrome can treat or cure nearly any disease, without drugs, diagnosis, or surgery, by restoring the body's color-based chemical balance.
Ghadiali marketed the Spectro-Chrome from 1920 as a system capable of treating virtually any ailment through colored light alone. A 1947 federal jury convicted him and his Institute of introducing a misbranded device into interstate commerce; the conviction was affirmed on appeal and the U.S. Supreme Court denied review, and in 1958 the FDA obtained a permanent injunction against a renamed successor device on the ground that it was the same misbranded article; the practitioner’s nonprofit successor stated in its own 2012 training manual that the injunction “still stands.”
Appears in
Sources
- The Science of Automatic Precision — Matthew Lavine, "The Science of Automatic Precision," Historical Studies in the Natural Sciences 44, no. 2 (April 2014): 140-177, University of California Press.
- 2389. Misbranding of Spectro-Chrome. U.S. v. Dinshah P. Ghadiali and Dinshah Spectro-Chrome Institute — U.S. Food and Drug Administration, Notice of Judgment 2389, "Misbranding of Spectro-Chrome," FDA Notices of Judgment Collection, 1908-1966 (District of New Jersey), issued April 1949; digitized by the National Library of Medicine.
- United States v. Ghadiali, 165 F.2d 957 (3d Cir. 1948); Ghadiali v. United States, 334 U.S. 821 (1948) — United States v. Ghadiali, 165 F.2d 957 (3d Cir., filed February 9, 1948); Ghadiali v. United States, 334 U.S. 821 (U.S. Supreme Court, certiorari denied May 17, 1948); court records indexed by CourtListener (Free Law Project).
- Let There Be Light: Practical Manual for Spectro-Chrome Therapy — Darius Dinshah, Let There Be Light: Practical Manual for Spectro-Chrome Therapy, 11th ed. (Malaga, N.J.: Dinshah Health Society, November 2012), ISBN 0-933917-32-5.